用塞特拉林进行计算机化认知行为疗法治疗精神分裂症与抑郁症发作:一项为期12周的随机对照试验
Ren-Chun Huang1, Nicha Wareesawetsuwan2, Nan Lin1
1Department of Psychiatry, Fuzhou Neuropsychiatric Hospital Affiliated to Fujian Medical University, Fuzhou 350004, Fujian Province, China.
World journal of psychiatry
|November 24, 2025
概括
与单独使用塞特拉林相比,计算机认知行为疗法 (CCBT) 与塞特拉林结合显著改善了精神分裂症患者的抑郁症状和认知功能. 这种辅助疗法提高了整体生活质量,提供了更有效的治疗选择.
科学领域:
- 精神病学是一个精神病学.
- 临床心理学 临床心理学
- 神经科学是一个神经科学.
背景情况:
- 精神分裂症经常与抑郁症并发,恶化认知缺陷并降低生活质量.
- 目前对这些并发症,特别是认知功能障碍的治疗方法有限.
研究的目的:
- 为了比较计算机化认知行为疗法 (CCBT) 加上赛特拉林与赛特拉林单一治疗的疗效.
- 评估精神分裂症和抑郁症发作患者抑郁症状,认知功能和生活质量的改善.
主要方法:
- 一项随机对照试验,涉及68名精神分裂症和抑郁症状的成年人.
- 参与者接受了CCBT与塞特拉林或塞特拉林单一治疗4周.
- 测量结果包括抑郁症状 (卡尔加里抑郁量表),认知功能 (MCCB) 和生活质量 (SF-36).
主要成果:
- 在12周后,CCBT加塞特拉林组的抑郁症状明显改善 (P < 0.001).
- 认知功能,包括处理速度和社会认知,在实验组中得到了更大的改善 (分别是P = 0.043和P = 0.006).
- 生活质量,特别是心理健康方面,在接受CCBT与塞特拉林组中显著改善.
结论:
- 使用塞特拉林的计算机认知行为疗法 (CCBT) 对患有抑郁症的精神分裂症患者比单一治疗更有效.
- 与塞特拉林一起的CCBT显示出作为改善抑郁症状,认知和生活质量的有效辅助疗法的潜力.
相关概念视频
01:25Cognitive Therapy
852
Cognitive therapy, pioneered by Aaron T. Beck in the 1960s, is a structured approach to addressing psychological distress by focusing on the influence of thoughts on emotions and behaviors. All cognitive therapies involve the basic assumption that human beings have control over their feelings, and that how individuals feel about something depends on how they think about it. Unlike psychoanalytic methods that delve into unconscious processes or humanistic approaches emphasizing...
852
01:30Electroconvulsive Therapy
820
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
820
01:23Antidepressant Drugs: MAOIs and Other Agents
776
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
776
01:24Rational Emotive Behavior Therapy
331
Cognitive-behavioral therapies (CBTs) are grounded in the belief that our thoughts profoundly influence our emotions and actions. Advocates of CBT emphasize three core assumptions: first, that cognitions are identifiable and measurable; second, that they are central to psychological functioning; and third, that irrational or maladaptive beliefs can be replaced with rational and adaptive ones. This transformative approach to therapy has paved the way for specific models such as Albert...
331
01:28Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
1.3K
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
1.3K
01:25Antidepressant Drugs: Overview
1.4K
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
1.4K